{
  "id": 772419,
  "title": "STAT+: Pharmalittle: We’re reading about California insulin sales, a Moderna patent battle, and more",
  "url": "https://urgent.news/2026/08/13/stat-pharmalittle-were-reading-about-california-insulin-sales-a",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-13T13:19:42.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/pharmalot/2026/08/13/california-insulin-sales-moderna-patent-battle/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Seven months after the launch of its own low-cost insulin brand, California has distributed more than 120,000 five-pen packs of insulin glargine priced at $55 each",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}